Vijay Kumar
Related Authors
Philip P W Wong
Taylor's University
Susumu Hirose
National Institute of Genetics
Lyndsay Rhodes
Florida Gulf Coast University
Tin Nguyen
University of Adelaide
Fabio Trovato
Pennsylvania State University
InterestsView All (31)
Uploads
Papers by Vijay Kumar
ubiquitin ligases are tightly regulated both at transcriptional and post-translational levels. The E3 ubiquitin ligase TRUSS (tumor necrosis factor receptor-associated ubiquitous scaffolding and signaling protein) which negatively regulates c-Myc, are found down-regulated in most human cancer cell lines. However, the mechanism of regulation of intracellular levels of TRUSS remains elusive. Here we show that TRUSS is expressed majorly during the G1 phase of cell cycle and its level starts to decline with the expression of S-phase specific E3 ligase Skp2. Enforced expression of Skp2 led to a marked increase in the ubiquitination of TRUSS after its phosphorylation by GSK3β and followed by rapid proteolytic degradation. Our coimmunoprecipitation studies suggested a direct interaction between Skp2 and TRUSS through the LRR motif of Skp2. Interestingly, the human tumor samples that exhibited elevated expression of Skp2, showed relatively poor expression of TRUSS. Further, enforced expression of HBx, the oncoprotein of Hepatitis B virus which is known to stabilize c-Myc and enhance its oncogenic potential, led to the intracellular accumulation of TRUSS as well as c-Myc. Apparently, HBx also interacted with TRUSS which negatively impacted the TRUSS-c-Myc and TRUSS-Skp2 interactions leading to stabilization of TRUSS. Thus, the present study suggests that TRUSS is a novel substrate of E3 ligase Skp2 and that disruption of TRUSS-Skp2
interaction by viral oncoproteins could lead to pathophysiological sequelae.
Though Yukyung Karne has been reported to be clinically effective, the molecular mechanism of its anti-metstatic
action remains elusive.
Methods: The cytotoxic property of Yukyung Karne was evaluated by crystal violet staining while its ability to induce
ceramide production was analyzed by sphingomyelinase assay. The anti-metastatic property was investigated using
adhesion, invasion, migration and colony formation assays. The effect of Yukyung Karne on the expression of extracellular
matrix components, and epithelial and mesenchymal markers were evaluated by confocal microscopy and
western blotting.
Results: Yukyung Karne exhibited a strong anti-metastatic property by significantly reducing the invasion,
migration and colony formation ability of ovarian cancer cells. Besides it inhibited the levels of biomarkers
involved in epithelial to mesenchymal transition such as down-regulation of vimentin and N-cadherin and
up-regulation of epithelial E-cadherin. Yukyung Karne also induced the neutral sphingomyelinase II (nSMNaseII)
enzyme activity that is known to hydrolyze sphingomyelins into pro-apoptotic intracellular molecule ceramide.
Conclusions: The study provides some compelling evidences supporting the anti-metastatic potential of Yukyung
Karne which strongly suggests its possible usage as a promising alternative medicine. Thus, Yukyung Karne may
be used as an anticance
and several host proteins that are known to support the development and progression of hepatocellular
carcinoma (HCC). While overexpression of the nucleolar phosphoprotein, nucleophosmin (NPM), correlates
with HCC progression, its upregulation by viral HBx and the resulting impact on perturbed nucleolar functions
remain enigmatic. The present study shows that HBx up-regulates NPM levels and hijacks its functions to
promote cellular proliferation. We found that HBx expression stabilizes NPM through post-translational modifications.
Enhanced CDK2-mediated phosphorylation of NPM at Thr199 upon HBx expression prevented its proteolytic cleavage and provided resistance to apoptosis. Further, HBx directly interacted with the C-terminal domain of NPM and got translocated into the nucleolus where it facilitated the recruitment of RNA polymerase I transcriptional machinery onto the rDNA promoter. Our results indicate that HBx enhances rDNA transcription via a novel regulatory mechanism involving acetylation of NPM and the subsequent depletion of histones from the rDNA promoter. Enhanced production of ribosomal RNA resulting from co-expression of HBx and NPM
promoted ribosome biogenesis, cellular proliferation and transformation. Taken together, our study strongly suggests an important role of NPM in mediating the oncogenic effects of HBx and the corresponding nucleolar perturbations induced by this viral oncoprotein.
Methods: The UBF gene expression was investigated after co-expressing HBx in immortalized human hepatocytes (IHH) and human hepatoma Huh7 cells. Gene expression analysis involved estimation of mRNA level by real-time PCR, western blotting of protein, chromatin immune-precipitation assay, BrdU incorporation assay and soft agar colony formation assay. UBF expression was also investigated in an HBx transgenic mouse model of HCC to get a better mechanistic insight under more physiological conditions.
Results: Ectopic expression of HBx in IHH as well as Huh7 cells led to a marked increase in UBF expression both at mRNA and protein levels. Elevated levels of UBF were also observed in the hepatic tumors of HBx transgenic mice. Our ChIP studies revealed a marked increase in the occupancy of c-Myc on the UBF gene promoter in the presence of HBx and increase in its transcription. Enhanced UBF expression under the HBx microenvironment led to a marked increase in cell proliferation and transformation of IHH cells.
Conclusions: Our study provides some compelling evidences in support of HBx-mediated increase in UBF levels that abets oncogenic onslaught in hepatic cells by increasing rDNA transcription and ribosome biogenesis.
cancer. Although the incidence rates remain higher in more
developed countries, mortality and morbidity are higher in less
developed regions, attributable to late detection and lack of access to advanced medical amenities. Regardless of epidemiological prevalence, the etiological determinants of breast cancer development remain common and include age, family history, genetic risk factors such as BRCA1 and BRCA2 mutations and hormonal risk factors. Although viruses have been etiologically associated with many cancers,
a viral etiology to breast cancer is at best speculative. There is
conflicting evidence of roles of viruses such as human mammary tumor virus, human papillomavirus, Epstein-Barr virus, human cytomegalovirus, herpes simplex virus and measles virus in breast cancer development. Nonetheless, a recent development that levels of mutagenic antiviral enzyme APOBEC3B are elevated in a majority of breast cancers warrants a re-visit to the role of viruses in breast cancer pathogenesis. Keeping in view the current scenario, there is
an urgency to assess the worldwide trends and risk factors for
prediction of future scenarios with the ultimate goal of developing effective, affordable and prioritized approaches for breast cancer control.
Methods: The growth inhibition property of YK was evaluated in SKOV6, IHH, HepG2 and HEK293 cell lines using MTT assay. The pro-apoptotic activity of drug was analyzed by terminal deoxynuleotidyl transferase dUTP nick end labeling (TUNEL) and DNA fragmentation assays. Confocal microscopy was used to show the release of cytochrome c and its co-localization with mitochondria with the help of dsRed mitotracker in SKOV6 cells. The inhibition in cell proliferation was also visualized by confocal microscopy after BrDU incorporation. The activation of tumor suppressor p53 was evaluated by Western blotting while the VEGF level in culture supernatant was measured by a colorimetric method.
Results: YK specifically and efficiently induced apoptotic killing of the human ovarian cancer SKOV6 cells as indicated by increased DNA fragmentation and nick end DNA labeling. Confocal microscopy suggested inhibition of cell proliferation and increase in cytochrome c release via perturbation in mitochondrial membrane potential (m). Further, YK up-regulated the expression of tumor suppressor p53 and key cyclin-dependent kinase inhibitor p21, and inhibited VEGF secretion by cells. Interestingly, YK also exhibited a synergy with paclitaxel which a well-known anti-cancer therapeutic drug.
Conclusions: The pharmacological properties of YK to impose growth arrest and trigger pro-apoptotic death in cells amply justifies its usage in primary as well as adjunct therapy for ovarian cancer.
towards the beginning of 20th century. The study of
tumour viruses, their oncogenes and different mechanisms
employed by these viruses to subvert the
growth-suppressive and pro-apoptotic functions of
host tumour suppressor genes has laid the foundation
of cancer biology. The human tumour viruses induce
malignancies after a prolonged latency and in conjunction
with other environmental and host factors.
The eight known human tumour viruses contribute to
nearly 10–15% of the cancers worldwide. Advancements
in research on virus-related cancers offer a
plethora of opportunities to fight cancer by preventing
viral spread through vaccination and use of antivirals.
Besides, recent developments on viral oncogenic
mechanisms should allow development of novel and
targeted approaches for control and treatment of
virus-associated human cancers.
ubiquitin ligases are tightly regulated both at transcriptional and post-translational levels. The E3 ubiquitin ligase TRUSS (tumor necrosis factor receptor-associated ubiquitous scaffolding and signaling protein) which negatively regulates c-Myc, are found down-regulated in most human cancer cell lines. However, the mechanism of regulation of intracellular levels of TRUSS remains elusive. Here we show that TRUSS is expressed majorly during the G1 phase of cell cycle and its level starts to decline with the expression of S-phase specific E3 ligase Skp2. Enforced expression of Skp2 led to a marked increase in the ubiquitination of TRUSS after its phosphorylation by GSK3β and followed by rapid proteolytic degradation. Our coimmunoprecipitation studies suggested a direct interaction between Skp2 and TRUSS through the LRR motif of Skp2. Interestingly, the human tumor samples that exhibited elevated expression of Skp2, showed relatively poor expression of TRUSS. Further, enforced expression of HBx, the oncoprotein of Hepatitis B virus which is known to stabilize c-Myc and enhance its oncogenic potential, led to the intracellular accumulation of TRUSS as well as c-Myc. Apparently, HBx also interacted with TRUSS which negatively impacted the TRUSS-c-Myc and TRUSS-Skp2 interactions leading to stabilization of TRUSS. Thus, the present study suggests that TRUSS is a novel substrate of E3 ligase Skp2 and that disruption of TRUSS-Skp2
interaction by viral oncoproteins could lead to pathophysiological sequelae.
Though Yukyung Karne has been reported to be clinically effective, the molecular mechanism of its anti-metstatic
action remains elusive.
Methods: The cytotoxic property of Yukyung Karne was evaluated by crystal violet staining while its ability to induce
ceramide production was analyzed by sphingomyelinase assay. The anti-metastatic property was investigated using
adhesion, invasion, migration and colony formation assays. The effect of Yukyung Karne on the expression of extracellular
matrix components, and epithelial and mesenchymal markers were evaluated by confocal microscopy and
western blotting.
Results: Yukyung Karne exhibited a strong anti-metastatic property by significantly reducing the invasion,
migration and colony formation ability of ovarian cancer cells. Besides it inhibited the levels of biomarkers
involved in epithelial to mesenchymal transition such as down-regulation of vimentin and N-cadherin and
up-regulation of epithelial E-cadherin. Yukyung Karne also induced the neutral sphingomyelinase II (nSMNaseII)
enzyme activity that is known to hydrolyze sphingomyelins into pro-apoptotic intracellular molecule ceramide.
Conclusions: The study provides some compelling evidences supporting the anti-metastatic potential of Yukyung
Karne which strongly suggests its possible usage as a promising alternative medicine. Thus, Yukyung Karne may
be used as an anticance
and several host proteins that are known to support the development and progression of hepatocellular
carcinoma (HCC). While overexpression of the nucleolar phosphoprotein, nucleophosmin (NPM), correlates
with HCC progression, its upregulation by viral HBx and the resulting impact on perturbed nucleolar functions
remain enigmatic. The present study shows that HBx up-regulates NPM levels and hijacks its functions to
promote cellular proliferation. We found that HBx expression stabilizes NPM through post-translational modifications.
Enhanced CDK2-mediated phosphorylation of NPM at Thr199 upon HBx expression prevented its proteolytic cleavage and provided resistance to apoptosis. Further, HBx directly interacted with the C-terminal domain of NPM and got translocated into the nucleolus where it facilitated the recruitment of RNA polymerase I transcriptional machinery onto the rDNA promoter. Our results indicate that HBx enhances rDNA transcription via a novel regulatory mechanism involving acetylation of NPM and the subsequent depletion of histones from the rDNA promoter. Enhanced production of ribosomal RNA resulting from co-expression of HBx and NPM
promoted ribosome biogenesis, cellular proliferation and transformation. Taken together, our study strongly suggests an important role of NPM in mediating the oncogenic effects of HBx and the corresponding nucleolar perturbations induced by this viral oncoprotein.
Methods: The UBF gene expression was investigated after co-expressing HBx in immortalized human hepatocytes (IHH) and human hepatoma Huh7 cells. Gene expression analysis involved estimation of mRNA level by real-time PCR, western blotting of protein, chromatin immune-precipitation assay, BrdU incorporation assay and soft agar colony formation assay. UBF expression was also investigated in an HBx transgenic mouse model of HCC to get a better mechanistic insight under more physiological conditions.
Results: Ectopic expression of HBx in IHH as well as Huh7 cells led to a marked increase in UBF expression both at mRNA and protein levels. Elevated levels of UBF were also observed in the hepatic tumors of HBx transgenic mice. Our ChIP studies revealed a marked increase in the occupancy of c-Myc on the UBF gene promoter in the presence of HBx and increase in its transcription. Enhanced UBF expression under the HBx microenvironment led to a marked increase in cell proliferation and transformation of IHH cells.
Conclusions: Our study provides some compelling evidences in support of HBx-mediated increase in UBF levels that abets oncogenic onslaught in hepatic cells by increasing rDNA transcription and ribosome biogenesis.
cancer. Although the incidence rates remain higher in more
developed countries, mortality and morbidity are higher in less
developed regions, attributable to late detection and lack of access to advanced medical amenities. Regardless of epidemiological prevalence, the etiological determinants of breast cancer development remain common and include age, family history, genetic risk factors such as BRCA1 and BRCA2 mutations and hormonal risk factors. Although viruses have been etiologically associated with many cancers,
a viral etiology to breast cancer is at best speculative. There is
conflicting evidence of roles of viruses such as human mammary tumor virus, human papillomavirus, Epstein-Barr virus, human cytomegalovirus, herpes simplex virus and measles virus in breast cancer development. Nonetheless, a recent development that levels of mutagenic antiviral enzyme APOBEC3B are elevated in a majority of breast cancers warrants a re-visit to the role of viruses in breast cancer pathogenesis. Keeping in view the current scenario, there is
an urgency to assess the worldwide trends and risk factors for
prediction of future scenarios with the ultimate goal of developing effective, affordable and prioritized approaches for breast cancer control.
Methods: The growth inhibition property of YK was evaluated in SKOV6, IHH, HepG2 and HEK293 cell lines using MTT assay. The pro-apoptotic activity of drug was analyzed by terminal deoxynuleotidyl transferase dUTP nick end labeling (TUNEL) and DNA fragmentation assays. Confocal microscopy was used to show the release of cytochrome c and its co-localization with mitochondria with the help of dsRed mitotracker in SKOV6 cells. The inhibition in cell proliferation was also visualized by confocal microscopy after BrDU incorporation. The activation of tumor suppressor p53 was evaluated by Western blotting while the VEGF level in culture supernatant was measured by a colorimetric method.
Results: YK specifically and efficiently induced apoptotic killing of the human ovarian cancer SKOV6 cells as indicated by increased DNA fragmentation and nick end DNA labeling. Confocal microscopy suggested inhibition of cell proliferation and increase in cytochrome c release via perturbation in mitochondrial membrane potential (m). Further, YK up-regulated the expression of tumor suppressor p53 and key cyclin-dependent kinase inhibitor p21, and inhibited VEGF secretion by cells. Interestingly, YK also exhibited a synergy with paclitaxel which a well-known anti-cancer therapeutic drug.
Conclusions: The pharmacological properties of YK to impose growth arrest and trigger pro-apoptotic death in cells amply justifies its usage in primary as well as adjunct therapy for ovarian cancer.
towards the beginning of 20th century. The study of
tumour viruses, their oncogenes and different mechanisms
employed by these viruses to subvert the
growth-suppressive and pro-apoptotic functions of
host tumour suppressor genes has laid the foundation
of cancer biology. The human tumour viruses induce
malignancies after a prolonged latency and in conjunction
with other environmental and host factors.
The eight known human tumour viruses contribute to
nearly 10–15% of the cancers worldwide. Advancements
in research on virus-related cancers offer a
plethora of opportunities to fight cancer by preventing
viral spread through vaccination and use of antivirals.
Besides, recent developments on viral oncogenic
mechanisms should allow development of novel and
targeted approaches for control and treatment of
virus-associated human cancers.